Richard Yu
Founder of Abalone Bio
San Francisco Bay Area
Overview
Work Experience
Co-founder and CEO
2018 - Current
Abalone Bio develops full-spectrum antibody drugs to access promising therapeutic targets and unlock new disease treatments.
Raised $1,474,998.00 from Asymmetry Ventures, Y Combinator, Milad Alucozai, Erik Peterson, Pioneer Fund and Harmonix Fund.
Advisor
2017 - 2018
Principal
2013 - 2016
COO and co-founder
2017 - 2018
Co-founder
2015 - 2016
Scientific and Operations Director, QB3@953 incubator
2013 - 2016
Co-Manager and Operations Director
2014 - 2016
Scientist
2013 - 2013
Investigator
2008 - 2013
Systems biology of and information handling by signal transduction pathways
Senior Research Fellow
2004 - 2008
Research Fellow
2000 - 2004
CSO and Co-founder
2009 - 2013
Dramatically improve the efficiency of algae biofuel production using synthetic cell engineering
Graduate Student
1995 - 2000
Department of Molecular Biophysics and Biochemistry Laboratory of Dr. Axel Brunger Structural biology of proteins involved in membrane fusion
Research Associate
1993 - 1995
Research, Computational Biology, Life Sciences Division Laboratory of Dr. Teresa Head-Gordon AI/ML and protein secondary structure prediction
Berkeley Lab is a national laboratory that creates advanced new tools for scientific discovery.